Page last updated: 2024-09-05

organophosphonates and slv 306

organophosphonates has been researched along with slv 306 in 2 studies

Compound Research Comparison

Studies
(organophosphonates)
Trials
(organophosphonates)
Recent Studies (post-2010)
(organophosphonates)
Studies
(slv 306)
Trials
(slv 306)
Recent Studies (post-2010) (slv 306)
9,9688803,5961237

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battistini, B; Gray, GA; Webb, DJ1
Emoto, N1

Reviews

1 review(s) available for organophosphonates and slv 306

ArticleYear
[Physiological and pathophysiological roles of the endothelin converting enzymes].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Animals; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Drug Design; Endothelin-Converting Enzymes; Glycopeptides; Heart Failure; Humans; Hypertension; Metalloendopeptidases; Mice; Mice, Knockout; Myocardial Infarction; Organophosphonates; Phenylalanine; Tetracyclines; Tetrazoles

2004

Other Studies

1 other study(ies) available for organophosphonates and slv 306

ArticleYear
Endothelins are potent vasoconstrictors, and much more besides.
    Trends in pharmacological sciences, 2000, Volume: 21, Issue:2

    Topics: Aspartic Acid Endopeptidases; Benzazepines; Benzhydryl Compounds; Benzofurans; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Endothelins; Enzyme Inhibitors; Heart Failure; Humans; Metalloendopeptidases; Organophosphonates; Pyrimidines; Vascular Diseases; Vasoconstrictor Agents

2000